Team

Pieter Nieuwland, PhD

CEO / Principal consultant

With a background in chemistry, Pieter has built up knowledge and experience how to translate small scale chemical reactions into automated processes. Having lead designs for several (semi-) automated setups for organic, inorganic and radiochemical processes, he now focuses fully on medical isotope processing and radiopharmaceutical manufacturing. As the managing director, he leads the company's daily operations and market strategies.

Dion van der Born, PhD

COO / Radiochemistry consultant

Dion has performed a PhD research project at the VU University Medical Centre. In this project, he has developed a novel methodology to incorporate a fluorine-18 labelled trifluoromethyl (CF3) functional group onto an aromate. This method enables the radiolabelling and biological evaluation of drugs and drug candidates which contain the CF3 group.

As a radiochemistry services consultant at FutureChemistry, Dion is responsible for the development of radiolabelled compounds and their biological evaluation.

Willem van Winkoop, MsC

Business Developer

After obtaining his Master's degree in biotechnology, Willem took on several roles that further developed his skills in technical and business disciplines. With hands-on experience in various fields, including both a year as fermentation scientist and a year as business analyst at a biotech startup, he now supports and fosters business ventures, partnerships, and collaborations at FutureChemistry.

As a Business Analyst, Willem bridges technical expertise with business development in the evolving radiopharmaceutical space.

Dirk Hinz, PhD

CMC and GMP consultant

Dirk is an independent CMC and GMP consultant with over 20 years of experience in pharmaceutical development and quality oversight. Formerly in senior QA roles at Bayer, he has extensive expertise in external manufacturing, CDMO oversight, and radiopharmaceutical development.

Advisory Board

Kees Groen, PhD

Advisor Pharma

Kees Groen is co-founder and CEO of DGr Pharma, CDO of Matisse Pharmaceuticals (sepsis), CFO of Orca Therapeutics (oncology), and founder and General Manager of Kinesis Pharma (drug development). He holds a PhD in Pharmaceutical Sciences and a BSc in law.

Kees has extensive experience in pharmaceutical research and development, both with regulatory authorities and in industry. He has held management and operational roles across preclinical and clinical development, regulatory affairs, and licensing. He possesses broad knowledge in both small molecules and biotechnological products. Kees holds non-executive positions in a number of companies.

Eric van 't Hooft, PhD

Advisor Medical Technology and Isotopes

Eric van 't Hooft was founder and managing director of Nucletron B.V. and has been active as executive board member of Delft Instruments N.V.. He holds a degree in mechanical engineering and has been decorated "Commandeur in de orde van de Nederlandse Leeuw".

Although retired from executive functions, he remains an indispensable source of knowledge in the fields of medical isotopes and medical technology.

Peter Rutgers, MSc.

Advisor Strategy

As Managing Director of Waterman Ventures, Peter supports growing businesses in developing and marketing technological innovations that address the world’s most pressing challenges. Prior to joining Waterman Ventures, he worked with the Boston Consulting Group in Amsterdam, where he specialized in Marketing and Sales as well as Corporate Ventures. Peter holds an MSc. in Industrial Engineering and Management, specialized in Product and Process Technology, from University of Groningen and an MBA from INSEAD.

Subscribe for company updates

No spam. Just major company announcements.

Location and contact

FutureChemistry is located in Wageningen, The Netherlands.
We work for clients throughout Europe.

Visiting and postal address:
FutureChemistry Holding BV
Betsy van Goorstraat 22
6702 DC, WAGENINGEN
The Netherlands

t: NL +31 (0) 85 2500 848
e: info@futurechemistry.com

Chamber of Commerce no. 09176926
Nijmegen, The Netherlands
VAT NL8188.26.320.B.01

"